REG - Hikma Pharmaceutical - Transaction in Own Shares
28/02/2022 18:45
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220228:nRSb1084Da&default-theme=true
RNS Number : 1084D Hikma Pharmaceuticals Plc 28 February 2022
Hikma Pharmaceuticals PLC
Share Buyback Programme
London, 28 February 2022
Hikma Pharmaceuticals PLC ("Hikma") announces today that it has purchased the
following number of its ordinary shares on the London Stock Exchange and/or on
BATS and/or on Chi-X trading venues from Citigroup Global Markets Limited
("Citi"). The repurchased shares will be cancelled.
London Stock Exchange BATS Trading Venue Chi-X Trading Venue
Number of ordinary shares purchased: 7,108 3,686 3,638
Highest price paid (per ordinary share): £20.0000 £20.0000 £20.2500
Lowest price paid (per ordinary share): £19.8150 £19.8700 £19.8750
Volume weighted average price paid (per ordinary share): £19.9572 £19.9650 £20.0467
Such purchases form part of Hikma's share buyback programme announced on 24
February 2022.
Following the settlement of the above purchases and cancellation of the
purchased ordinary shares, the total number of ordinary shares in issue shall
be 244,146,355 ordinary shares and the total number of ordinary shares held in
treasury is 12,833,233 ordinary shares. Therefore, following the above
purchases total voting rights are 231,313,122 ordinary shares.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), the detailed breakdown of individual trades made by Citi on
behalf of Hikma as part of the buyback programme is set out below.
This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.
Schedule of Purchases - Individual Transactions
Date of Transaction Time of Transaction Number of Shares Price Per Share (GBp) Trading Venue Transaction Reference Number
28/02/2022 09:18:30 117 2,025.00 CHIX xsqApDVDfEk
28/02/2022 09:18:30 51 2,024.00 CHIX xsqApDVDfEe
28/02/2022 09:18:30 28 2,024.00 CHIX xsqApDVDfEg
28/02/2022 09:24:04 90 2,024.00 CHIX xsqApDVDiMF
28/02/2022 09:24:04 41 2,024.00 CHIX xsqApDVDiMH
28/02/2022 09:20:45 55 2,024.00 CHIX xsqApDVDhE@
28/02/2022 09:20:45 29 2,024.00 CHIX xsqApDVDhE0
28/02/2022 09:15:18 143 2,022.00 CHIX xsqApDVDKcO
28/02/2022 09:12:55 91 2,021.00 CHIX xsqApDVDIyX
28/02/2022 09:06:19 107 2,020.00 CHIX xsqApDVDVBN
28/02/2022 09:09:14 93 2,020.00 CHIX xsqApDVDH3P
28/02/2022 09:09:14 3 2,020.00 CHIX xsqApDVDH3R
28/02/2022 09:11:09 95 2,017.00 CHIX xsqApDVDJVJ
28/02/2022 09:11:09 31 2,017.00 CHIX xsqApDVDJVL
28/02/2022 09:03:56 66 2,013.00 CHIX xsqApDVDQhR
28/02/2022 09:03:56 50 2,013.00 CHIX xsqApDVDQhT
28/02/2022 09:03:59 79 2,013.00 CHIX xsqApDVDQfh
28/02/2022 08:08:56 62 2,000.00 CHIX xsqApDVEaGi
28/02/2022 08:09:00 149 2,000.00 CHIX xsqApDVEaKq
28/02/2022 08:26:11 124 2,000.00 XLON xsqApDVEmdV
28/02/2022 08:26:11 37 2,000.00 XLON xsqApDVEmcX
28/02/2022 08:26:11 95 2,000.00 CHIX xsqApDVEmcZ
28/02/2022 08:26:11 104 2,000.00 BATE xsqApDVEmcb
28/02/2022 08:11:04 5 2,000.00 BATE xsqApDVEcRH
28/02/2022 08:11:04 188 2,000.00 XLON xsqApDVEcR9
28/02/2022 08:11:04 47 2,000.00 BATE xsqApDVEcRJ
28/02/2022 08:40:18 201 2,000.00 XLON xsqApDVDBXk
28/02/2022 08:11:04 23 2,000.00 BATE xsqApDVEcRB
28/02/2022 08:11:04 9 2,000.00 BATE xsqApDVEcRD
28/02/2022 08:11:04 3 2,000.00 BATE xsqApDVEcRF
28/02/2022 08:06:05 105 2,000.00 CHIX xsqApDVEZoZ
28/02/2022 08:06:05 201 2,000.00 XLON xsqApDVEZof
28/02/2022 08:09:44 83 2,000.00 BATE xsqApDVEdR$
28/02/2022 08:09:43 9 2,000.00 BATE xsqApDVEaaH
28/02/2022 08:09:43 17 2,000.00 BATE xsqApDVEaaJ
28/02/2022 08:09:43 4 2,000.00 BATE xsqApDVEaaL
28/02/2022 08:09:43 42 2,000.00 CHIX xsqApDVEaaT
28/02/2022 08:09:43 124 2,000.00 XLON xsqApDVEaaF
28/02/2022 08:09:43 109 2,000.00 CHIX xsqApDVEaaV
28/02/2022 08:09:43 9 2,000.00 BATE xsqApDVEaaN
28/02/2022 08:09:43 25 2,000.00 BATE xsqApDVEaaP
28/02/2022 08:09:43 23 2,000.00 BATE xsqApDVEaaR
28/02/2022 08:40:59 69 2,000.00 BATE xsqApDVDAFc
28/02/2022 08:36:57 150 2,000.00 CHIX xsqApDVD9ot
28/02/2022 08:40:59 131 2,000.00 XLON xsqApDVDAFa
28/02/2022 08:40:59 64 2,000.00 BATE xsqApDVDAFe
28/02/2022 08:36:57 118 2,000.00 BATE xsqApDVD9ov
28/02/2022 08:40:59 122 2,000.00 CHIX xsqApDVDAFg
28/02/2022 08:36:57 147 2,000.00 XLON xsqApDVD9or
28/02/2022 08:06:06 138 2,000.00 BATE xsqApDVEZpt
28/02/2022 08:45:06 69 2,000.00 XLON xsqApDVDCrr
28/02/2022 08:32:33 98 2,000.00 CHIX xsqApDVEqZV
28/02/2022 08:32:33 110 2,000.00 XLON xsqApDVEqZT
28/02/2022 08:11:04 97 1,999.50 XLON xsqApDVEcR7
28/02/2022 08:11:04 14 1,999.50 XLON xsqApDVEcR5
28/02/2022 08:00:53 83 1,999.50 XLON xsqApDVEisj
28/02/2022 08:06:05 93 1,999.50 XLON xsqApDVEZob
28/02/2022 08:09:43 66 1,999.50 XLON xsqApDVEaaD
28/02/2022 08:09:43 7 1,999.50 XLON xsqApDVEaaB
28/02/2022 08:40:59 64 1,999.50 BATE xsqApDVDAFW
28/02/2022 08:40:59 73 1,999.50 CHIX xsqApDVDAFY
28/02/2022 08:40:59 131 1,999.50 XLON xsqApDVDACR
28/02/2022 08:36:57 86 1,999.50 XLON xsqApDVD9op
28/02/2022 08:45:06 81 1,999.50 BATE xsqApDVDCrk
28/02/2022 08:40:59 26 1,999.50 BATE xsqApDVDACU
28/02/2022 08:32:33 8 1,999.50 CHIX xsqApDVEqZN
28/02/2022 08:32:33 26 1,999.50 CHIX xsqApDVEqZP
28/02/2022 08:32:33 32 1,999.50 CHIX xsqApDVEqZR
28/02/2022 08:16:32 59 1,999.00 XLON xsqApDVEw$h
28/02/2022 08:16:32 80 1,999.00 XLON xsqApDVEwyB
28/02/2022 08:16:32 82 1,999.00 XLON xsqApDVEwyD
28/02/2022 08:16:32 159 1,998.50 XLON xsqApDVEwyR
28/02/2022 08:11:04 159 1,998.50 BATE xsqApDVEcRg
28/02/2022 08:11:04 164 1,998.50 BATE xsqApDVEcRu
28/02/2022 08:16:32 100 1,998.50 XLON xsqApDVEw$j
28/02/2022 08:12:00 127 1,998.50 BATE xsqApDVEceY
28/02/2022 08:12:00 46 1,998.50 CHIX xsqApDVEcea
28/02/2022 08:12:00 25 1,998.50 CHIX xsqApDVEcec
28/02/2022 08:09:46 66 1,998.50 BATE xsqApDVEdPN
28/02/2022 08:09:43 83 1,998.50 BATE xsqApDVEaah
28/02/2022 08:08:49 136 1,998.50 CHIX xsqApDVEaP7
28/02/2022 08:12:22 96 1,998.50 BATE xsqApDVEvUQ
28/02/2022 08:12:22 44 1,998.50 CHIX xsqApDVEvUS
28/02/2022 08:12:22 94 1,998.50 XLON xsqApDVEvUM
28/02/2022 08:12:22 42 1,998.50 CHIX xsqApDVEvUU
28/02/2022 08:12:00 15 1,998.00 XLON xsqApDVEcfS
28/02/2022 08:12:00 100 1,998.00 XLON xsqApDVEcfU
28/02/2022 08:12:00 86 1,998.00 BATE xsqApDVEceW
28/02/2022 08:12:22 65 1,998.00 BATE xsqApDVEvUO
28/02/2022 08:43:31 100 1,997.50 XLON xsqApDVDDlY
28/02/2022 08:43:31 87 1,997.50 BATE xsqApDVDDle
28/02/2022 08:43:31 98 1,997.50 CHIX xsqApDVDDlg
28/02/2022 08:43:31 40 1,997.50 CHIX xsqApDVDDli
28/02/2022 08:43:31 34 1,997.00 CHIX xsqApDVDDla
28/02/2022 08:43:31 66 1,997.00 XLON xsqApDVDDlW
28/02/2022 08:43:31 68 1,997.00 CHIX xsqApDVDDlc
28/02/2022 08:43:31 176 1,997.00 BATE xsqApDVDDiK
28/02/2022 08:16:34 118 1,996.50 XLON xsqApDVEwoN
28/02/2022 08:16:55 11 1,996.50 BATE xsqApDVEwZE
28/02/2022 08:16:55 19 1,996.50 BATE xsqApDVEwZG
28/02/2022 08:16:55 11 1,996.50 XLON xsqApDVEwZA
28/02/2022 08:16:55 100 1,996.50 BATE xsqApDVEwZI
28/02/2022 08:07:01 154 1,996.50 XLON xsqApDVEYrZ
28/02/2022 08:16:55 91 1,996.50 XLON xsqApDVEwZC
28/02/2022 08:17:01 11 1,996.50 XLON xsqApDVEwbp
28/02/2022 08:43:31 66 1,996.50 XLON xsqApDVDDiR
28/02/2022 08:23:34 187 1,996.00 XLON xsqApDVEn19
28/02/2022 08:23:34 116 1,996.00 CHIX xsqApDVEn1B
28/02/2022 08:16:07 2 1,996.00 CHIX xsqApDVEwAC
28/02/2022 08:16:07 90 1,996.00 CHIX xsqApDVEwAE
28/02/2022 08:16:07 118 1,996.00 XLON xsqApDVEwAA
28/02/2022 08:16:07 16 1,996.00 CHIX xsqApDVEwAG
28/02/2022 08:14:25 76 1,996.00 CHIX xsqApDVEufr
28/02/2022 08:16:36 164 1,996.00 XLON xsqApDVEwmG
28/02/2022 08:17:01 80 1,996.00 BATE xsqApDVEwba
28/02/2022 08:17:01 116 1,996.00 XLON xsqApDVEwbZ
28/02/2022 08:17:01 74 1,996.00 BATE xsqApDVEwbl
28/02/2022 08:17:01 78 1,996.00 XLON xsqApDVEwbn
28/02/2022 08:17:01 15 1,996.00 BATE xsqApDVEwbr
28/02/2022 08:23:34 118 1,995.50 BATE xsqApDVEn17
28/02/2022 08:23:34 129 1,995.50 XLON xsqApDVEn15
28/02/2022 08:14:25 125 1,995.50 XLON xsqApDVEufp
28/02/2022 08:07:12 74 1,995.50 XLON xsqApDVEYcS
28/02/2022 08:07:12 9 1,995.50 XLON xsqApDVEYcU
28/02/2022 08:17:01 79 1,995.50 XLON xsqApDVEzQU
28/02/2022 08:34:26 93 1,995.50 CHIX xsqApDVEsQS
28/02/2022 08:22:59 83 1,995.50 XLON xsqApDVE@bC
28/02/2022 08:34:26 128 1,995.50 BATE xsqApDVEsQU
28/02/2022 08:12:59 42 1,995.00 BATE xsqApDVEv@m
28/02/2022 08:12:59 64 1,995.00 BATE xsqApDVEv@o
28/02/2022 08:14:25 122 1,995.00 XLON xsqApDVEufn
28/02/2022 08:21:02 116 1,995.00 XLON xsqApDVE$oi
28/02/2022 08:23:05 2 1,995.00 XLON xsqApDVEnUu
28/02/2022 08:23:05 98 1,995.00 XLON xsqApDVEnUw
28/02/2022 08:34:26 99 1,995.00 XLON xsqApDVEsQE
28/02/2022 08:34:26 88 1,995.00 BATE xsqApDVEsQJ
28/02/2022 08:34:26 133 1,995.00 XLON xsqApDVEsQQ
28/02/2022 08:13:03 43 1,994.50 BATE xsqApDVEvp$
28/02/2022 08:13:03 45 1,994.50 BATE xsqApDVEvp1
28/02/2022 08:13:03 19 1,994.50 BATE xsqApDVEvp3
28/02/2022 08:13:03 83 1,994.50 XLON xsqApDVEvpz
28/02/2022 08:22:16 116 1,994.50 XLON xsqApDVE@1k
28/02/2022 08:22:16 34 1,994.50 CHIX xsqApDVE@1i
28/02/2022 08:22:16 81 1,994.50 CHIX xsqApDVE@1e
28/02/2022 08:22:16 103 1,994.50 BATE xsqApDVE@1g
28/02/2022 08:07:31 163 1,994.50 XLON xsqApDVEbHm
28/02/2022 08:21:02 52 1,994.50 XLON xsqApDVE$og
28/02/2022 08:21:02 24 1,994.50 XLON xsqApDVE$od
28/02/2022 08:21:02 3 1,994.50 XLON xsqApDVE$of
28/02/2022 08:34:26 77 1,994.50 XLON xsqApDVEsQO
28/02/2022 08:13:03 107 1,994.00 BATE xsqApDVEvpo
28/02/2022 08:13:03 101 1,994.00 XLON xsqApDVEvpv
28/02/2022 08:13:03 12 1,994.00 XLON xsqApDVEvpx
28/02/2022 08:22:16 79 1,994.00 XLON xsqApDVE@1c
28/02/2022 08:22:16 89 1,994.00 XLON xsqApDVE@6K
28/02/2022 08:22:16 89 1,994.00 BATE xsqApDVE@6R
28/02/2022 08:14:25 91 1,994.00 XLON xsqApDVEufe
28/02/2022 08:07:31 90 1,994.00 XLON xsqApDVEbHf
28/02/2022 08:07:31 110 1,994.00 XLON xsqApDVEbHk
28/02/2022 08:21:03 123 1,994.00 BATE xsqApDVE$mo
28/02/2022 08:21:03 83 1,994.00 XLON xsqApDVE$mz
28/02/2022 08:14:25 128 1,993.50 XLON xsqApDVEufd
28/02/2022 08:07:31 89 1,993.50 XLON xsqApDVEbHa
28/02/2022 08:17:41 114 1,993.00 CHIX xsqApDVEz3J
28/02/2022 08:00:34 128 1,991.00 CHIX xsqApDVEi4E
28/02/2022 08:00:35 75 1,990.50 BATE xsqApDVEi5h
28/02/2022 08:00:30 22 1,990.50 BATE xsqApDVEi05
28/02/2022 08:00:35 65 1,990.00 BATE xsqApDVEi5j
28/02/2022 08:00:39 83 1,989.00 XLON xsqApDVEivb
28/02/2022 08:19:36 146 1,987.50 BATE xsqApDVEyqj
28/02/2022 08:19:36 6 1,987.50 XLON xsqApDVEyqf
28/02/2022 08:19:36 110 1,987.50 XLON xsqApDVEyqd
28/02/2022 08:19:36 115 1,987.50 CHIX xsqApDVEyqh
28/02/2022 08:19:37 4 1,987.00 BATE xsqApDVEyrC
28/02/2022 08:19:37 12 1,987.00 BATE xsqApDVEyrE
28/02/2022 08:19:36 8 1,987.00 BATE xsqApDVEyrT
28/02/2022 08:19:36 10 1,987.00 BATE xsqApDVEyrV
28/02/2022 08:19:36 11 1,987.00 BATE xsqApDVEyqX
28/02/2022 08:19:36 22 1,987.00 BATE xsqApDVEyqZ
28/02/2022 08:19:36 79 1,987.00 XLON xsqApDVEyrR
28/02/2022 08:19:36 13 1,987.00 BATE xsqApDVEyqb
28/02/2022 08:19:37 114 1,987.00 XLON xsqApDVEyrA
28/02/2022 08:18:00 159 1,985.50 XLON xsqApDVEzos
28/02/2022 08:18:00 20 1,985.50 XLON xsqApDVEzou
28/02/2022 08:00:25 200 1,981.50 XLON xsqApDVEi9L
-- ENDS --
Enquiries:
Hikma Pharmaceuticals PLC
Peter Speirs +44 (0)20 7399 2772
Company Secretary
Susan Ringdal +44 (0)20 7399 2760
EVP Strategy and Global Affairs
About Hikma
Hikma helps put better health within reach every day for millions of people
around the world. For more than 40 years, we've been creating high-quality
medicines and making them accessible to the people who need them.
Headquartered in the UK, we are a global company with a local presence across
the United States (US), the Middle East and North Africa (MENA) and Europe,
and we use our unique insight and expertise to transform cutting-edge science
into innovative solutions that transform people's lives. We're committed to
our customers, and the people they care for, and by thinking creatively and
acting practically, we provide them with a broad range of branded and
non-branded generic medicines. Together, our 8,700 colleagues are helping to
shape a healthier world that enriches all our communities. We are a leading
licensing partner, and through our venture capital arm, are helping bring
innovative health technologies to people around the world. For more
information, please visit: www.hikma.com (http://www.hikma.com) .
(LEI:549300BNS685UXH4JI75)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSVVLFLLLLXBBERecent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Fitch upgrades Hikma to ‘BBB’
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
Announcement